Search

Your search keyword '"Diffuse large B-Cell lymphoma"' showing total 19,327 results
Start Over "Diffuse large B-Cell lymphoma" Publication Type News
19,327 results on '"Diffuse large B-Cell lymphoma"'

2. CHMP recommends EU approval of Roche's Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

Subjects
Roche Holding AG, Non-Hodgkin's lymphomas -- Development and progression, B cells, Chemotherapy, Cancer -- Chemotherapy, Business, Business, international, Columvi (Medication)
Abstract

M2 PRESSWIRE-March 3, 2025-: CHMP recommends EU approval of Roche's Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma (C)1994-2025 M2 COMMUNICATIONS RDATE:02032025 - Columvi plus chemotherapy [...]

Published
2025

3. Diffuse Large B-Cell Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Subjects
Nektar Therapeutics -- Product development, Sanofi S.A. -- Product development, Product development, Non-Hodgkin lymphomas, Clinical trials, Business research, Medical research, Drug approval, Bendamustine, Business -- Research, Medicine, Experimental, Non-Hodgkin's lymphomas
Abstract

M2 PRESSWIRE-February 18, 2025-: Diffuse Large B-Cell Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies (C)1994-2025 M2 COMMUNICATIONS RDATE:17022025 DelveInsight's, 'Diffuse [...]

Published
2025

4. Diffuse Large B-cell Lymphoma Market Expected to rise, 2034 | Calithera Biosciences, IMV, Roche, Biogen, Autolus Therapeutics, Allogene Therapeutics, Novartis, Miltenyi Biomedicine, Regeneron Pharmace

Subjects
Biological products industry -- Market size -- Industry forecasts, Lymphomas -- Care and treatment -- Market research -- Forecasts and trends, Marketing research, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 17, 2025-: Diffuse Large B-cell Lymphoma Market Expected to rise, 2034 | Calithera Biosciences, IMV, Roche, Biogen, Autolus Therapeutics, Allogene Therapeutics, Novartis, Miltenyi Biomedicine, Regeneron Pharmace (C)1994-2025 M2 [...]

Published
2025

7. U.S. FDA Approves Pfizer's ADCETRIS(r) Combination Regimen for the treatment of Relapsed|Refractory Diffuse Large B-Cell Lymphoma

Subjects
Pfizer Inc., Adcetris (Medication), Drug therapy, Non-Hodgkin lymphomas -- Drug therapy, B cells, Hematopoietic stem cell transplantation, Stem cells, Drug approval, Non-Hodgkin's lymphomas -- Drug therapy, Hematopoietic stem cells -- Transplantation
Abstract

NEW YORK: PFIZER INC has issued the following news release: Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License [...]

Published
2025

10. Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

Subjects
Merck & Company Inc. -- Product development, Care and treatment, Evaluation, Product development, Non-Hodgkin lymphomas -- Care and treatment, Clinical trials, Vincristine -- Product development -- Evaluation, Biopharmaceuticals -- Evaluation -- Product development, Antibodies, Biopharmaceutics -- Evaluation -- Product development, Viral antibodies, Non-Hodgkin's lymphomas -- Care and treatment
Abstract

Expansion of the waveLINE clinical development program demonstrates company's progress in advancing research in hematologic malignancies RAHWAY, N.J. -- Merck (NYSE: MRK), known as MSD outside of the United States [...]

Published
2025

11. Diffuse Large B-cell Lymphoma Pipeline Drugs Report 2024 (Updated) | DelveInsight

Subjects
Nektar Therapeutics -- Reports, Sanofi S.A. -- Reports, Business -- Research, Biotechnology industry -- Reports, Non-Hodgkin's lymphomas -- Drug therapy, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 13, 2024-: Diffuse Large B-cell Lymphoma Pipeline Drugs Report 2024 (Updated) | DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:13112024 DelveInsight's, 'Diffuse Large B-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive [...]

Published
2024

12. Merck launches Phase 3 trial for zilovertamab vedotin in diffuse large B-cell lymphoma

Subjects
Merck & Company Inc., Clinical trials, Vincristine, Pharmaceutical industry, Biological products, Lymphomas
Abstract

M2 EQUITYBITES-February 6, 2025-Merck launches Phase 3 trial for zilovertamab vedotin in diffuse large B-cell lymphoma (C)2025 M2 COMMUNICATIONS http://www.m2.co.uk US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as [...]

Published
2025

13. Merck launches Phase 3 trial for zilovertamab vedotin in diffuse large B-cell lymphoma

Subjects
Merck & Company Inc., Clinical trials, Vincristine, Pharmaceutical industry, Biological products, Lymphomas
Abstract

M2 PHARMA-February 6, 2025-Merck launches Phase 3 trial for zilovertamab vedotin in diffuse large B-cell lymphoma (C)2025 M2 COMMUNICATIONS US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD [...]

Published
2025

14. ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

Subjects
Zynlonta (Medication), ADC Therapeutics S.A., United States. Food and Drug Administration
Abstract

ENPNewswire-December 31, 2024--ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma (C)2024 ENPublishing - http://www.enpublishing.co.uk [...]

Published
2024

15. ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed, Refractory Diffuse Large B-cell Lymphoma

Subjects
ADC Therapeutics S.A., Zynlonta (Medication)
Abstract

ENPNewswire-December 12, 2024--ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed, Refractory Diffuse Large B-cell Lymphoma (C)2024 ENPublishing [...]

Published
2024

17. Diffuse large B-cell lymphoma

Subjects
Bone marrow transplantation, Non-Hodgkin lymphomas, B cells, Stem cells, Bone marrow -- Transplantation, Non-Hodgkin's lymphomas
Abstract

Description A fast-growing, common cancer of the body's germ- and disease-fighting system, called the lymphatic system. Overview Diffuse large B-cell lymphoma is a fast-growing, common cancer of the body's germ- [...]

Published
2024

18. EU Contract Notice: Universitatsklinikum Munster Issues contract notice|solicitation for 'IIT study CLEAR 'Combining Loncastuximab Tesirine and Epcoritamab in Relapsed|Refractory Diffuse Large B-cell Lymphoma (DLBCL)'

Subjects
Lymphomas, Contract agreement, Business, international
Abstract

Luxembourg: Universitatsklinikum Munster has issued contract notice/solicitation for 'IIT study CLEAR 'Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)' Reference no: 639713-2024 Posted on: 22/10/2024 Notice [...]

Published
2024

19. Researchers from National Cancer Centre Singapore Publish Research in B-Cell Lymphoma (Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia)

Subjects
Biochemistry -- Research, Oncology, Experimental, T cells -- Research, Antineoplastic agents -- Research, Lymphomas -- Research -- Care and treatment, Antigens -- Research, Cancer -- Care and treatment -- Research, Antimitotic agents -- Research, Health
Abstract

2025 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on B-cell lymphoma is now available. According to news reporting [...]

Published
2025

20. Debre Tabor University Researchers Update Understanding of B-Cell Lymphoma [Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review]

Subjects
Biochemistry, Lymphomas, Epidemiology, Health
Abstract

2025 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Research findings on B-cell lymphoma are discussed in a new report. According to news reporting [...]

Published
2025

22. Capital Medical University Researchers Update Current Data on B-Cell Lymphoma (Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma)

Subjects
Biochemistry -- Research, Stem cells -- Research, Lymphomas -- Research -- Prognosis, Enzyme inhibitors -- Research, Machine learning -- Research, Health
Abstract

2025 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A new study on B-cell lymphoma is now available. According to news reporting originating from [...]

Published
2025

23. Sun Yat-sen University Cancer Center Researchers Describe Research in B-Cell Lymphoma (PI3Kd inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm ...)

Subjects
Oncology, Experimental, Biochemistry -- Research, Antineoplastic agents -- Research, Lymphomas -- Research, Cancer -- Research, Antimitotic agents -- Research, Health
Abstract

2025 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on B-cell lymphoma have been published. According to news reporting [...]

Published
2025

24. Study Results from Uppsala University Broaden Understanding of Genetics (Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival)

Subjects
Genetic research -- Reports -- Genetic aspects, Diseases -- Relapse, Cancer -- Genetic aspects, Biological sciences, Health, Uppsala University -- Reports
Abstract

2025 FEB 25 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Research findings on genetics are discussed in a new report. According to news reporting [...]

Published
2025

25. Researchers at Second Medical Center Zero in on B-Cell Lymphoma (Case report: From misdiagnosis to timely detection: a clinical and imaging guide to neurological presentations of diffuse large B-cell lymphoma-insights from six cases)

Subjects
Biochemistry, Medical centers, Lymphomas, Health
Abstract

2025 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A new study on B-cell lymphoma is now available. According to news originating from Beijing, [...]

Published
2025

26. Study Findings on B-Cell Lymphoma Published by Researchers at Second Affiliated Hospital of Nanjing Medical University (Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels)

Subjects
Care and treatment, Analysis, Research, Reports, Biochemistry -- Analysis -- Research -- Reports, Lymphomas -- Research -- Care and treatment
Abstract

2025 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on B-cell lymphoma have been published. According to news reporting [...]

Published
2025

27. Studies in the Area of B-Cell Lymphoma Reported from Clinical Laboratory (APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway)

Subjects
Apoptosis, Biomedical laboratories, Apolipoproteins, Lymphomas, Medical laboratories
Abstract

2025 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on B-cell lymphoma is now available. According to news reporting [...]

Published
2025

28. Research Results from University of Crete Update Understanding of B-Cell Lymphoma (Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma)

Subjects
Exhibitions, Research, Non-Hodgkin lymphomas -- Research, T cells -- Research, Non-Hodgkin's lymphomas -- Research
Abstract

2025 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in B-cell lymphoma. According to news reporting from Heraklion, [...]

Published
2025

29. Research on B-Cell Lymphoma Discussed by Researchers at Department of Hematology and Medical Oncology (Circulating Free RNA as a Therapeutic Evaluation in Diffuse Large B-cell Lymphoma: A Case Series from the Indonesian Cancer Center)

Subjects
Research, Vincristine -- Research, Cancer, Chemotherapy -- Research, Biochemistry -- Research, Lymphomas -- Research, RNA -- Research, Cancer -- Chemotherapy
Abstract

2025 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on B-cell lymphoma have been presented. According to news reporting from Jakarta, Indonesia, [...]

Published
2025

30. Reports from University of Utah Describe Recent Advances in B-Cell Lymphoma (Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma)

Subjects
The University of Utah, Care and treatment, Non-Hodgkin lymphomas -- Care and treatment, Antigens, Stem cells, Stem cell transplantation, T cells, Stem cells -- Transplantation, Non-Hodgkin's lymphomas -- Care and treatment
Abstract

2025 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Current study results on B-cell lymphoma have been published. According to news reporting from the [...]

Published
2025

31. New B-Cell Lymphoma Study Findings Recently Were Published by Researchers at Capital Medical University (Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key ...)

Subjects
Analysis, Research, Prognosis, Reports, Biochemistry -- Analysis -- Research -- Reports, Lymphomas -- Research -- Prognosis
Abstract

2025 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on B-cell lymphoma. According to news reporting from Capital Medical University [...]

Published
2025

32. New B-Cell Lymphoma Study Findings Recently Were Reported by Researchers at Genentech Inc. (Gneseqcoo: a Novel Method for Classifying Diffuse Large B-cell Lymphoma Cell of Origin Based On Bulk Tumor Rna Sequencing Profiles)

Subjects
Prognosis, Reports, Methods, Non-Hodgkin lymphomas -- Prognosis, Chief operating officers -- Methods -- Reports, Biochemistry -- Methods -- Reports, Biological products industry -- Methods -- Reports, Non-Hodgkin's lymphomas -- Prognosis
Abstract

2025 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on Oncology - B-Cell Lymphoma. According to news originating from South [...]

Published
2025

33. Findings on B-Cell Lymphoma Reported by Investigators at Yan'an University (Identification of Key Genes and Drug Recommendations In Diffuse Large B-cell Lymphoma Based On Analysis of Glutathione-related Genes)

Subjects
Analysis, Genetic research -- Analysis, Cancer genetics -- Analysis, Genes -- Analysis, Thiols -- Analysis, Lymphomas -- Analysis, Cancer -- Genetic aspects
Abstract

2025 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators discuss new findings in Oncology - B-Cell Lymphoma. According to news reporting originating in [...]

Published
2025

34. Studies from Qingdao University Update Current Data on B-Cell Lymphoma (Usp37 Promotes Diffuse Large B-cell Lymphoma Progression By Deubiquitinating and Stabilizing C-myc)

Subjects
Development and progression, Research, Prognosis, Lung cancer -- Research -- Development and progression -- Prognosis, Lymphomas -- Research -- Development and progression -- Prognosis
Abstract

2025 FEB 7 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Oncology - B-Cell Lymphoma is the subject of a report. [...]

Published
2025

35. Reports on Muscular Atrophy Findings from Guangdong Provincial People's Hospital Provide New Insights (Pet/computed Tomography Radiomics Combined With Clinical Features In Predicting Sarcopenia and Prognosis of Diffuse Large B-cell Lymphoma)

Subjects
Research, Reports, Sarcopenia -- Research, Tomography -- Research -- Reports, Machine learning -- Reports -- Research, Medical research -- Reports, Lymphomas -- Research, Medicine, Experimental -- Reports
Abstract

2025 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on Musculoskeletal Diseases and Conditions - Muscular Atrophy. According to news [...]

Published
2025

38. Studies from Ohio State University Further Understanding of B-Cell Lymphoma (Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma)

Subjects
The Ohio State University, Care and treatment, Patient outcomes, Non-Hodgkin lymphomas -- Care and treatment -- Patient outcomes, Non-Hodgkin's lymphomas -- Care and treatment -- Patient outcomes
Abstract

2025 JAN 31 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on B-cell lymphoma are presented in a new report. According to [...]

Published
2025

40. Reports on B-Cell Lymphoma Findings from University of Copenhagen Provide New Insights (Limited Benefit of Routine Clinical Follow-up for Relapse Detection In Diffuse Large B-cell Lymphoma Patients In Complete Remission Following First-line ...)

Subjects
University of Copenhagen, Care and treatment, Research, Lymphomas -- Research -- Care and treatment
Abstract

2025 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Data detailed on Oncology - B-Cell Lymphoma have been presented. According to news reporting originating [...]

Published
2025

42. Zhejiang University School of Medicine Researcher Reveals New Findings on Artificial Intelligence [Artificial Intelligence-Driven Precision Medicine: Multi-Omics and Spatial Multi-Omics Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)]

Subjects
Research, Artificial intelligence, Precision medicine -- Research, Artificial intelligence -- Research, Lymphomas -- Research
Abstract

2025 JAN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in artificial intelligence. According to news reporting originating from [...]

Published
2025

43. Researchers at Chiang Mai University Report Research in Personalized Medicine (Critical Role of Extracellular Vesicles in Diffuse Large B-Cell Lymphoma; Pathogenesis, Potential Biomarkers, and Targeted Therapy-A Narrative Review)

Subjects
Reports, Precision medicine -- Reports, Lymphomas -- Reports
Abstract

2025 JAN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on personalized medicine. According to news originating from Chiang [...]

Published
2025

45. Recent Findings in Adrenal Insufficiency Described by Researchers from Cukurova University (A Rare Case Report of Adrenal Gland Diffuse Large B-cell Lymphoma Presenting With Pituitary Insufficiency Findings)

Subjects
Research, Non-Hodgkin lymphomas -- Research, Non-Hodgkin's lymphomas -- Research
Abstract

2025 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Research findings on adrenal insufficiency are discussed in a new report. According to news originating [...]

Published
2025

46. New B-Cell Lymphoma Study Findings Have Been Reported from Division of Hematology (Management of Chemotherapy-resistant Gastric Diffuse Large B-cell Lymphoma: A Case Report)

Subjects
Care and treatment, Research, Non-Hodgkin lymphomas -- Care and treatment -- Research, Chemotherapy -- Research, Non-Hodgkin's lymphomas -- Care and treatment -- Research, Cancer -- Chemotherapy
Abstract

2025 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on B-cell lymphoma. According to news originating from the Division of [...]

Published
2025

47. Research from University of Colombo in the Area of Autoimmune Hemolytic Anemia Described ('Bone marrow-liver-spleen-type diffuse large B-cell lymphoma' presenting with cold autoimmune hemolytic anemia: a case report)

Subjects
University of Colombo, Research, Hemolytic anemia -- Research, Liver -- Research, Lymphomas -- Research
Abstract

2025 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on autoimmune hemolytic anemia are presented in a new report. According [...]

Published
2025

Catalog

Books, media, physical & digital resources
See catalog results